PURPOSE: Mutations in RMRP primarily give rise to Cartilage Hair Hypoplasia (CHH), a highly diverse skeletal disorder which can be associated with severe immunodeficiency. Increased availability of RMRP mutation screening has uncovered a number of infants with significant immunodeficiency but only mild or absent skeletal features. We surveyed the clinical and immunological phenotype of children who have undergone allogeneic haematopoietic stem cell transplantation for this condition in the UK. METHODS: Thirteen patients with confirmed RMRP mutations underwent allogeneic stem cell transplantation (SCT) at two nationally commissioned centres using a variety of donors and conditioning regimens. Records were retrospectively reviewed. RESULTS: Median time from clinical presentation to diagnosis was 12 months (range 1 to 276 months), with three infants diagnosed with severe combined immunodeficiency (SCID) without radiographical manifestations of CHH. A total of 17 allogeneic procedures were performed on 13 patients including two stem-cell top-ups. The median age at transplant was 32.4 months (range 1.5 to 125 months). Of the eleven surviving patients, median follow-up was 50 months (range 21.6 to 168 months). CONCLUSIONS: RMRP mutations can cause short stature and significant immunodeficiency which can be corrected by allogeneic SCT and the diagnosis should be considered even in the absence of skeletal manifestations.
PURPOSE: Mutations in RMRP primarily give rise to Cartilage Hair Hypoplasia (CHH), a highly diverse skeletal disorder which can be associated with severe immunodeficiency. Increased availability of RMRP mutation screening has uncovered a number of infants with significant immunodeficiency but only mild or absent skeletal features. We surveyed the clinical and immunological phenotype of children who have undergone allogeneic haematopoietic stem cell transplantation for this condition in the UK. METHODS: Thirteen patients with confirmed RMRP mutations underwent allogeneic stem cell transplantation (SCT) at two nationally commissioned centres using a variety of donors and conditioning regimens. Records were retrospectively reviewed. RESULTS: Median time from clinical presentation to diagnosis was 12 months (range 1 to 276 months), with three infants diagnosed with severe combined immunodeficiency (SCID) without radiographical manifestations of CHH. A total of 17 allogeneic procedures were performed on 13 patients including two stem-cell top-ups. The median age at transplant was 32.4 months (range 1.5 to 125 months). Of the eleven surviving patients, median follow-up was 50 months (range 21.6 to 168 months). CONCLUSIONS: RMRP mutations can cause short stature and significant immunodeficiency which can be corrected by allogeneic SCT and the diagnosis should be considered even in the absence of skeletal manifestations.
Authors: Jacalyn L Gerstel-Thompson; Jonathan F Wilkey; Jennifer C Baptiste; Jennifer S Navas; Sung-Yun Pai; Kenneth A Pass; Roger B Eaton; Anne Marie Comeau Journal: Clin Chem Date: 2010-07-21 Impact factor: 8.327
Authors: Pia Hermanns; Alison A Bertuch; Terry K Bertin; Brian Dawson; Mark E Schmitt; Chad Shaw; Bernhard Zabel; Brendan Lee Journal: Hum Mol Genet Date: 2005-10-27 Impact factor: 6.150
Authors: Mervi Taskinen; Annamari Ranki; Eero Pukkala; Leila Jeskanen; Ilkka Kaitila; Outi Mäkitie Journal: Am J Med Genet A Date: 2008-09-15 Impact factor: 2.802
Authors: Antonia Kwan; Joseph A Church; Morton J Cowan; Rajni Agarwal; Neena Kapoor; Donald B Kohn; David B Lewis; Sean A McGhee; Theodore B Moore; E Richard Stiehm; Matthew Porteus; Constantino P Aznar; Robert Currier; Fred Lorey; Jennifer M Puck Journal: J Allergy Clin Immunol Date: 2013-07 Impact factor: 10.793
Authors: Liza J McCann; Jo McPartland; Dawn Barge; Lisa Strain; David Bourn; Eduardo Calonje; Julian Verbov; Andrew Riordan; George Kokai; Chris M Bacon; Michael Wright; Mario Abinun Journal: J Clin Immunol Date: 2013-11-12 Impact factor: 8.317
Authors: Robert Sertori; Jian-Xin Lin; Esteban Martinez; Sadhna Rana; Andrew Sharo; Majid Kazemian; Uma Sunderam; Mark Andrake; Susan Shinton; Billy Truong; Roland M Dunbrack; Chengyu Liu; Rajgopol Srinivasan; Steven E Brenner; Christine M Seroogy; Jennifer M Puck; Warren J Leonard; David L Wiest Journal: Front Immunol Date: 2022-07-29 Impact factor: 8.786